Abstract

Phospholipase Cϵ (PLCϵ), an effector of Ras and Rap small GTPases, plays a crucial role in inflammation by augmenting proinflammatory cytokine expression. This proinflammatory function of PLCϵ is implicated in its facilitative role in tumor promotion and progression during skin and colorectal carcinogenesis, although their direct link remains to be established. Moreover, the molecular mechanism underlying these functions of PLCϵ remains unknown except that PKD works downstream of PLCϵ. Here we show by employing the colitis-induced colorectal carcinogenesis model, where Apc(Min) (/+) mice are administered with dextran sulfate sodium, that PLCϵ knock-out alleviates the colitis and suppresses the following tumorigenesis concomitant with marked attenuation of proinflammatory cytokine expression. In human colon epithelial Caco2 cells, TNF-α induces sustained expression of proinflammatory molecules and sustained activation of nuclear factor-κB (NF-κB) and PKD, the late phases of which are suppressed by not only siRNA-mediated PLCϵ knockdown but also treatment with a lysophosphatidic acid (LPA) receptor antagonist. Also, LPA stimulation induces these events in an early time course, suggesting that LPA mediates TNF-α signaling in an autocrine manner. Moreover, PLCϵ knockdown results in inhibition of phosphorylation of IκB by ribosomal S6 kinase (RSK) but not by IκB kinases. Subcellular fractionation suggests that enhanced phosphorylation of a scaffolding protein, PEA15 (phosphoprotein enriched in astrocytes 15), downstream of the PLCϵ-PKD axis causes sustained cytoplasmic localization of phosphorylated RSK, thereby facilitating IκB phosphorylation in the cytoplasm. These results suggest the crucial role of the TNF-α-LPA-LPA receptor-PLCϵ-PKD-PEA15-RSK-IκB-NF-κB pathway in facilitating inflammation and inflammation-associated carcinogenesis in the colon.

Highlights

  • Phosphatidylinositol-specific PLCs3 catalyze the hydrolysis of phosphatidylinositol 4,5-bisphosphate into two vital second messengers, inositol 1,4,5-trisphosphate and diacylglycerol, which induce release of Ca2ϩ from the intracellular stores and activation of diacylglycerol target proteins, including PKC isoforms, respectively

  • We have shown that PLC⑀ augments inflammatory reactions by facilitating the proinflammatory cytokine expression in the colon administered with DSS

  • PLC⑀⌬X/⌬X mice showed markedly attenuated responses to DSS administration, represented by reduced expression of the proinflammatory molecules, such as TNF-␣, COX-2, CXCL1, CXCL2, and CCL2 (Fig. 1D), all of which had been implicated in the pathogenesis of DSS-induced colitis and human inflammatory bowel diseases [42, 43, 51,52,53,54,55,56,57,58]

Read more

Summary

Experimental Procedures

Materials—The following antibodies were obtained from Cell Signaling Technologies: rabbit anti-p65 RelA mAb (catalog no. 8242), rabbit anti-PKD Ab (catalog no. 2052), rabbit antiphospho-PKD (Ser-916) Ab (catalog no. 2051), rabbit anti-RSK mAb (catalog no. 5528), rabbit anti-phospho-RSK (Ser-380) mAb (catalog no. 11989), rabbit anti-I␬B Ab (catalog no. 9242), rabbit anti-phospho-I␬B (Ser-32) mAb (catalog no. 2859), rabbit anti-ERK Ab (catalog no. 9102), rabbit anti-phospho-ERK (Thr-202/Tyr-204) Ab (catalog no. 9101), rabbit anti-phosphoIKK␣/␤ (Ser-176/180) mAb (catalog no. 2697), rabbit antiPEA15 Ab (catalog no. 2780), rabbit anti-phospho-PEA15 (Ser104) Ab (catalog no. 2776), mouse anti-HA tag mAb (catalog no. 2367), and anti-␣-tubulin (catalog no. 3873) Ab. Materials—The following antibodies were obtained from Cell Signaling Technologies: rabbit anti-p65 RelA mAb 3873) Ab. The following antibodies were commercially obtained: rabbit anti-PLC⑀ Ab (HPA015597, Sigma), mouse anti-actin mAb (MAB1501R, Chemicon), rabbit anti-IKK␣/␤ Ab (sc-7607, Santa Cruz Biotechnology, Inc.), rabbit anti-TBP Ab (sc-273, Santa Cruz Biotechnology), rabbit anti-FLAG-tag Ab (PM020, MBL), goat anti-CCL2 (CC chemokine ligand 2) Ab (sc-1785, Santa Cruz Biotechnology), and goat anti-CXCL2 (chemokine CXC motif ligand 2) Ab (AF-452-NA, R&D Systems). The lipasedead human PLC⑀ mutant, PLC⑀⌬X, was generated by PCR-mediated mutagenesis to delete amino acids 1391– 1541. PCMV-HA-PEA15 was constructed by inserting the human PEA15 cDNA, obtained by RT-PCR using Caco cell mRNA as a template, into pCMV-HA (Clontech). Cells were pretreated with inhibitors and antagonists before stimulation by ligands, such as TNF-␣ and LPA

PCR Cloning
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call